Related Experiment Videos
RXRalpha: a novel target for prostate cancer
Krishan K Pandey1, Surinder K Batra
1Department of Biochemistry and Molecular Biology, The Eppley Institute for Research in Cancer and Allied Diseases, University of Nebraska Medical Center, Omaha, Nebraska 58198-4525, USA.
Cancer Biology & Therapy
|May 17, 2003
Summary
No abstract available in PubMed .
Related Concept Videos
Articles linked to this work by shared authors, journal, and citation graph.
Integrase Inhibitors: Redefining HIV-1 Treatment and Future Challenges.
Missouri medicine·2026
Delineation of a novel assembly intermediate in Rous sarcoma virus integration pathway.
Nucleic acids research·2026
An anomalous high-pressure phase and decompression-induced amorphization in dinitrotoluene.
The Journal of chemical physics·2025
From orphan to oncogene: The role of GPR35 in cancer and immune modulation.
Cytokine & growth factor reviews·2024
Effective treatment of human breast tumors by chimeric CCL2 and CCL8 diphtheria toxin cytotoxic peptides.
Cancer biology & therapy·2026
<i>NSUN2</i> mediates <i>SALL2</i> m5C methylation to inhibit ferroptosis and promote breast cancer progression.
Cancer biology & therapy·2026
Targeting the PI3K/AKT pathway in prostate cancer: the role of PTEN deficiency and biomarker-guided therapy.
Cancer biology & therapy·2026
ABHD17C regulates the efficacy of lenvatinib in suppressing hepatocellular carcinoma.
Cancer biology & therapy·2026
Statistical analysis plan considerations for autologous cell and cell-based gene therapy clinical trials.
Journal of biopharmaceutical statistics·2026
Nanosensitive optical coherence tomography to monitor corneal burn and treatment response in vivo.
Biomedical optics express·2026
Contemporary perspectives on metabolic surgery for type 2 diabetes: surgical techniques, outcomes, and complications.
Frontiers in endocrinology·2026